UC Pancreatic Cancer Consortium
UC Cancer Consortium – Chair:
Alan Ashworth
UC Pancreatic Cancer Consortium – UC Leaders:
UC Davis Comprehensive Cancer Center – Richard Bold
UCI Health Chao Family Comprehensive Cancer Center – Murray Korc
UCLA Jonsson Comprehensive Cancer Center – Timothy Donahue
UC San Diego Moores Cancer Center – Andrew Lowy
UCSF Helen Diller Family Comprehensive Cancer Center – Margaret Tempero
Left to right; Dr’s Richard Bold, Andrew Lowy, Margaret Tempero, Tannishtha Reya, Julie Sutcliffe and Katie Couric at the Stand Up To Cancer 2019 Scientific Summit in Santa Monica, CA.
Biobanking:
David Dawson (UCLA)
Chang-il Hwang (UC Davis)
Alfredo Molinolo (UCSD)
Scott VandenBerg (UCSF)
Early Biology:
Guido Eibl (UCLA)
Michael Karin (UCSD)
Rushika Perera (UCSF)
Early Detection:
Gobind Anand (UCSD)
Mustafa Arain (UCSF)
Amie Blanco (UCSF)
Richard Bold (UC Davis)
Paige Bracci (UCSF)
Kenneth Chang (UCI)
Sun-Chuan Dai (UCSF)
Dena Goldberg (UCSF)
Stephen Kim (UCLA)
Kimberly Kirkwood (UCSF)
Venkataraman (Raman) Muthusamy (UCLA)
Jason Samarasena (UCI)
Imaging:
Johannes Czernin (UCLA)
Michael Hahn (UCSD)
Julie Sutcliffe (UC Davis)
Zhen (Jane) Wang (UCSF)
Inherited Susceptibility:
Julia Carnevale (UCSF)
Luis Carvajal-Carmona (UC Davis)
Wendy Conlon (UCLA)
Dena Goldberg (UCSF)
Lisa Madlensky (UCSD)
PDAC Clinical Trials:
Sepideh Gholami (UC Davis)
Edward Kim (UC Davis)
Andrew Ko (UCSF)
Aaron M. Miller (UCSD)
Hitendra (Hiten) Patel (UCSD)
Caius Radu (UCLA)
Zev Wainberg (UCLA)
PNET:
Martin Allen-Auerbach (UCLA)
Emily Bergsland (UCSF)
Johannes Czernin (UCLA)
Paul Fanta (UCSD)
Cameron Foster (UC Davis)
Randy (Joel) Hecht (UCLA)
Thomas Hope (UCSF)
Nancy Joseph (UCSF)
Edward Kim (UC Davis)
Karen E. Matsukuma (UC Davis)
Eric Nakakura (UCSF)
Julie Sutcliffe (UC Davis)
Robert Warren (UCSF)
Ronald Wolf (UCI)
Technology Assessment:
Eric Collisson (UCSF)
John McPherson (UC Davis)
UC Pancreatic Cancer Consortium Working Groups:
Funding Opportunities
UC Pancreatic Cancer Consortium SPORE Projects
The UC Pancreatic Cancer Consortium submitted a Specialized Program of Research Excellence (SPORE) application to the NCI in May 2020. While the infrastructure scored highly, reviewers were critical of the projects to varying degrees. The Consortium is planning another submission in September 2021 with new and/or revised projects.
SPORE projects must be translational with a laboratory component and a human application, and are typically collaborations between basic and clinical researchers. Project budgets are expected to be in the region of $200,000–$250,000/yr for 5 years, although projects on early detection, prevention, or population science can request up to an additional $120,000/yr.
UCPCC Collaborative Pilot Project Award
The UC Pancreatic Cancer Consortium will fund a one-year pilot to encourage collaboration between UC campuses, with the expectation that it will lead to submission of a major collaborative grant such as an NIH P01, multi-PI R01, or similar. One award will be given up to $150,000.